Home › Chronic-Phase Myeloid Leukemia › Texas › Houston
Chronic-Phase Myeloid Leukemia clinical trials in Houston, TX
5 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Personalized NK Cell Therapy in CBT
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
RecruitingPhase 1/2
- The University of Texas M.D. Anderson Cancer Center, Houston
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
- Ascentage Investigative Site #1501, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Chronic-Phase Myeloid Leukemia trials in other cities
Other studies in Houston
- Non-Small Cell Lung Cancer143 studies
- Breast Cancer126 studies
- Cancer (all types)124 studies
- Colorectal Cancer101 studies
- Metastatic Cancer100 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia88 studies
- Lung Cancer78 studies
- Prostate Cancer73 studies
- Endometrial Cancer69 studies
- Melanoma61 studies
- Pancreatic Cancer59 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.